Latest Breaking News On - Amikacin liposome - Page 1 : vimarsana.com

Insmed Gains On Positive Phase 3 Results From ARISE Study Of Arikayce

Insmed Inc. (INSM) shares are progressing more than 18 percent on Tuesday morning after announcing positive results from the phase 3 ARISE study of Arikayce or Amikacin Liposome inhalation suspension in patients with nontuberculous mycobacterial or NTM lung disease caused by Mycobacterium avium complex.

Amikacin liposomeInsmed incStock alert

Insmed Gains On Positive Phase 3 Results From ARISE Study Of Arikayce

Insmed Gains On Positive Phase 3 Results From ARISE Study Of Arikayce
rttnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rttnews.com Daily Mail and Mail on Sunday newspapers.

Amikacin liposomeInsmed inc

Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference

Brensocatib Reduced Risk of Exacerbations Irrespective of Disease Severity in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE) in Phase 2 WILLOW.

United statesNew jerseyBryan dunnMandy faheyAmikacin liposomePharma gmbEleanor barisserMartina flammerDiagnosis groupDrug administrationPrnewswire insmed incorporated nasdaqInsmed incorporatedInternational conferenceResearch registryCorporate communicationsExchange commission